PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Ariad Pharmaceuticals, Inc. (NYSE: ARIA) | Delayed: 24.71 +0.64 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.07 | 52 Week High | $14.34 | |||
| Open | $24.71 | 52 Week Low | $4.37 | |||
| Day High | $24.71 | P/E | N/A | |||
| Day Low | $24.71 | EPS | $-1.45 | |||
| Volume | 7 | |||||
| PDL BioPharma, Inc. (NASDAQ: PDLI) | Delayed: 2.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.47 | 52 Week High | $4.06 | |||
| Open | $0.14 | 52 Week Low | $2.58 | |||
| Day High | $2.47 | P/E | 1.44 | |||
| Day Low | $2.47 | EPS | $1.71 | |||
| Volume | 1,000 | |||||
